Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.
Beato-Víbora PI, Gil-Poch E, Galán-Bueno L, Lázaro-Martín L, Arroyo-Díez FJ. Beato-Víbora PI, et al. J Diabetes Sci Technol. 2018 Nov;12(6):1241-1243. doi: 10.1177/1932296818791536. Epub 2018 Jul 30. J Diabetes Sci Technol. 2018. PMID: 30058373 Free PMC article. Clinical Trial. No abstract available.
A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.
Beato-Víbora P, Chico-Ballesteros A, Giménez M, Guerrero-Vázquez R, Barrio-Castellanos R, Goñi-Iriarte MJ, Díaz-Soto G, Merino-Torres JF, Moreno-Fernández J, Martínez-Brocca MA; Diabetes Technology Working Group of the Spanish Diabetes Association. Beato-Víbora P, et al. Diabetes Res Clin Pract. 2018 Mar;137:56-63. doi: 10.1016/j.diabres.2017.12.009. Epub 2017 Dec 24. Diabetes Res Clin Pract. 2018. PMID: 29278712
Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI, Quirós-López C, Lázaro-Martín L, Martín-Frías M, Barrio-Castellanos R, Gil-Poch E, Arroyo-Díez FJ, Giménez-Álvarez M. Beato-Víbora PI, et al. Diabetes Technol Ther. 2018 Nov;20(11):738-743. doi: 10.1089/dia.2018.0199. Epub 2018 Sep 25. Diabetes Technol Ther. 2018. PMID: 30256132
New uses and formulations of glucagon for hypoglycaemia.
Beato-Víbora PI, Arroyo-Díez FJ. Beato-Víbora PI, et al. Drugs Context. 2019 Jul 30;8:212599. doi: 10.7573/dic.212599. eCollection 2019. Drugs Context. 2019. PMID: 31402931 Free PMC article. Review.
Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
Beato-Víbora PI, Gallego-Gamero F, Lázaro-Martín L, Romero-Pérez MDM, Arroyo-Díez FJ. Beato-Víbora PI, et al. Diabetes Technol Ther. 2020 Dec;22(12):912-919. doi: 10.1089/dia.2019.0400. Epub 2020 Aug 28. Diabetes Technol Ther. 2020. PMID: 31855446
25 results